Medicated chitin fiber for treating and preventing proliferation of mammary gland, prepn. method and application thereof

A technology of chitosan fiber and mammary gland hyperplasia, which is applied in the field of medicinal fiber, can solve problems such as strong odor, and achieve the effect of simple production process, easy realization, and small side effects

Active Publication Date: 2008-12-31
LANGSHA KNITTING
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] The object of the present invention is to: provide a kind of medicinal chitosan fiber, to overcome the big defect of existing medicinal fabric smell

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] A kind of preparation method of the medicinal chitosan fiber of prevention and treatment mammary gland hyperplasia:

[0024] The first step is to prepare spinning dope. The chitosan-containing spinning dope is firstly prepared according to the existing technology, and each component is calculated by weight percentage, wherein the dry solid content of the chitosan is 99%. Then the medicine for preventing and treating mammary gland hyperplasia and the drug transdermal absorption accelerator are added in the spinning stock solution and stirred evenly. 0.5%;

[0025] The second step is to make medicinal chitosan fibers from the spinning stock solution containing anti-mammary gland hyperplasia drugs and drug transdermal absorption accelerators, and use wet spinning technology to make medicinal chitosan fibers that contain both shell Polysaccharides also contain drugs for preventing and treating mammary gland hyperplasia and drug transdermal absorption accelerators;

[002...

Embodiment 2

[0033] In the present embodiment, the dry solid content of chitosan in the spinning dope is 80%, the dry solid content of the anti-mammary gland hyperplasia medicine is 15%, and the dry solid content of the drug transdermal absorption accelerator is 5%.

[0034] The method is that the medicinal chitosan fiber is prepared from the spinning stock solution containing the drug for preventing and treating mammary gland hyperplasia and the drug transdermal absorption accelerator, and adopts a dry spinning process.

Embodiment 3

[0036] In this embodiment, the dry solid content of chitosan in the spinning dope is 70%, the dry solid content of the drug for preventing and treating mammary gland hyperplasia is 20%, and the dry solid content of the drug transdermal absorption accelerator is 10%.

[0037] The method is that the medicinal chitosan fiber is prepared from the spinning stock solution containing the anti-mammary gland hyperplasia drug and the transdermal absorption accelerator of the drug, and adopts a dry jet wet spinning process.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A medical chitosan fiber for preventing and treating mastoplasia contains proportionally chitosan, the active medicine chosen from tamoxifen, isoflavone, bromocriptine, etc, and the perecutaneous absorption promoter chosen from nitrone, oleic acid, N-methyl-2-pyrrolindone, propanediol and borneol. It can be used to weave fabric and then to make bra for preventing and treating mastoplasia.

Description

technical field [0001] The invention relates to a medical fiber, in particular to a medicinal chitosan fiber for preventing hyperplasia of mammary glands, a manufacturing method and application thereof. Background technique [0002] Mammary gland hyperplasia is the most common breast disease, and its incidence rate accounts for the first place in breast diseases. For the treatment of mammary gland hyperplasia, traditional Chinese medicine generally takes orally or externally applies some traditional Chinese medicines that soothe the liver, regulate qi, activate blood and remove blood stasis; Western medicine uses hormone drugs or surgical treatment. The effect of traditional Chinese medicine treatment of this disease is better, but the oral treatment of traditional Chinese medicine is loaded down with trivial details because of boiling medicine, and the medication time is long, and the patient is difficult to adhere to, and the curative effect of western medicine treatment o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/138A61K31/352A61K31/48A61K47/36A61K47/30A61P17/00
Inventor 朱利民樊在霞
Owner LANGSHA KNITTING
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap